Primary Job Title CSO & Co-founder Primary Organization Genomenon
Location Ann Arbor, Michigan, United States Regions Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Mark J. Kiel is Founder and Chief Science Officer at Genomenon where he oversees the company’s scientific direction and product development. Prior to starting Genomenon, Mark completed his residency in Clinical Pathology in 2014 at the University of Michigan. While at Michigan, he completed a fellowship in Molecular Diagnostics and devised the
informatics framework for clinical next-generation sequencing in the Molecular Diagnostics Laboratory. While a post-doctoral researcher under Drs. Kojo Elenitoba-Johnson and Megan Lim, he made significant contributions to the field of Hematopathology including genomic profiling of lymphoid malignancies for which he was awarded the Benjamin Castleman Award. During his doctoral studies with Sean Morrison, he made seminal contributions to the study of hematopoietic stem cells for which he was awarded the Weintraub International Graduate Student Award and the ProQuest Distinguished Dissertation Award.
